AstraZeneca Strives for Recovery Amidst China Probe with New R&D Hub in Beijing

In a bold move following a recent investigation by Chinese authorities, AstraZeneca is setting up a new research and development hub in Beijing. This initiative marks the pharmaceutical giant's commitment to deepening its presence in China and pivoting past the scrutiny that has affected its operations in the region.

Continue reading